ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 490

First Report of Symptoms Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire

Marian van Beers-Tas1, Lilian van Tuyl2, Karim Raza3, Rebecca J Stack4, Axel Finckh5, Delphine Courvoisier6, Aase Hensvold7, Anca I Catrina7, Tanja A. Stamm8, Erika Mosor9 and Dirkjan van Schaardenburg10, 1Rheumatology, Amsterdam Rheumatology & Immunology Center, Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center, location VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 3University of Birmingham, Rheumatology Research Group, Institute of Inflammation and Ageing, United Kingdom, Birmingham, United Kingdom, 4Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom, 5Rheumatology Division, University Hospital of Geneva, Geneva, Switzerland, 6University hospital of Geneva, Geneva, Switzerland, 7Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 8Internal Medicine III, Vienna Medical University, Vienna, Austria, 9Section for Outcomes Research, CeMSIIS, Medical University of Vienna, Vienna, Austria, 10Rheumatology, Amsterdam Rheumatology and immunology Center, location Academic Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: qualitative, questionnaires and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Persons at risk of rheumatoid arthritis (RA) may experience a variety of symptoms1,2. However, information on location, timing, severity and predictive value of these symptoms is largely lacking. The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire has been developed with support of EULAR to provide more insight into these symptoms. Aim of the study is to report the symptoms and symptom complexes using  the SPARRA questionnaire in an international group of arthralgia patients at risk of developing RA.

Methods: The SPARRA questionnaire contains questions on presence, severity, impact and location of 13 symptoms derived from a qualitative study in seropositive arthralgia patients1. The items are: joint pain or swelling, joint stiffness, burning and tingling sensations, numbness, changes in skin colour, muscle cramps, weakness, fatigue, emotional distress, concentration difficulties and sleep problems. Answers are given on an ordinal scale. If present, number of days with a symptom per month (0, 1-5, 6-15, 16-30 days), severity (none, mild, moderate and severe) and influence (no, small, moderate or high impact) were recorded. Secondly, we recorded the location of joint pain. Finally, patients were asked to describe the pattern of symptom development over time. Patients were included in the Netherlands (N=68), United Kingdom (N=16), Sweden (N=15), Austria (N=11) and Switzerland (N=21). Validation of the questionnaire is ongoing.

Results: Of 131 arthralgia patients included, 85 were positive for anti-citrullinated protein antibodies (ACPA), 29 were positive for rheumatoid factor only, and 17 were seronegative with clinically suspect arthralgia. Most symptoms were present in a high percentage of patients, with pain as the most often experienced symptom and change of skin color rarely reported. When a symptom was present, it was usually experienced as moderate to severe, and with moderate impact by half of the patients (Table 1). The mean presence of symptoms was similar in the ACPA positive and negative groups, however, ACPA positive patients more often had severe symptoms (mean 61% versus 54%, NS) with higher impact (48% versus 41%, NS). Joint pain was most frequently located in the fingers. The most frequently reported pattern of symptoms was "coming and going, but always present" (32%).

Conclusion: The first results of the SPARRA questionnaire show multiple symptoms to be present in a high percentage of persons at risk for RA. These are often experienced as severe, with a high impact.   References:

1.       Stack, Rheumatology 2014

2.       van Tuyl, Musculoskel Care 2015  

Table 1: First results of the SPARRA questionnaire (N=131)
Items Duration At least 1 day in the past month Severity If present, moderate to severe Influence If present, moderate or high impact
Joint pain

79%

66%

54%

Joint swelling

35%

52%

50%

Joint stiffness

69%

68%

44%

Burning sensations

29%

63%

60%

Tingling sensations

39%

56%

39%

Numbness

27%

49%

44%

Change in skin colour

15%

40%

25%

Muscle cramps

41%

41%

21%

Weakness or loss of strength

62%

67%

54%

Fatigue

72%

76%

65%

Emotional distress

52%

54%

43%

Concentration difficulties

37%

56%

48%

Sleep problems

54%

70%

52%

  .


Disclosure: M. van Beers-Tas, None; L. van Tuyl, None; K. Raza, None; R. J. Stack, None; A. Finckh, None; D. Courvoisier, None; A. Hensvold, None; A. I. Catrina, None; T. A. Stamm, None; E. Mosor, None; D. van Schaardenburg, None.

To cite this abstract in AMA style:

van Beers-Tas M, van Tuyl L, Raza K, Stack RJ, Finckh A, Courvoisier D, Hensvold A, Catrina AI, Stamm TA, Mosor E, van Schaardenburg D. First Report of Symptoms Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/first-report-of-symptoms-using-the-symptoms-in-persons-at-risk-of-rheumatoid-arthritis-sparra-questionnaire/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/first-report-of-symptoms-using-the-symptoms-in-persons-at-risk-of-rheumatoid-arthritis-sparra-questionnaire/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology